Gaucher cells are not associated with α-synuclein neuropathology in infants

Clinical Neuropathology

Volumn 35, Issue 3, 2016, Pages 122-128

  Berger Sieczkowski, Evelyn ^a   Lutz, Mirjam I ^b   Auff, Eduard ^a   Kovacs, Gabor G ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gaucher cells; Gaucher disease; Lewy body; Parkinson disease; synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ARTICLE; BRAIN STEM; CEREBELLUM; CHILD; CONTROLLED STUDY; DENTATE NUCLEUS; FEMALE; GAUCHER DISEASE; GLIOSIS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PURKINJE CELL; WHITE MATTER; BRAIN; HISTIOCYTE; METABOLISM; PATHOLOGY;

ALPHA-SYNUCLEIN; BRAIN; CHILD, PRESCHOOL; FEMALE; GAUCHER DISEASE; HISTIOCYTES; HUMANS; INFANT; MALE;

EID: 84968880358     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300901     Document Type: Article

References (35)

1. Beutler E, Grabowski G. A. Glucosylceramide lipidoses. In: Beaudet AL, Scriver CR, Sly WS (eds). The Metabolic Basis of Inherited Disease. New York: McGraw-Hill; 1995. p. 2641-2670
2. McKeran RO, Bradbury P, Taylor D, Stern G. Neurological involvement in type 1 (adult) Gaucher's disease. J Neurol Neurosurg Psychiatry. 1985; 48: 172-175
3. Neudorfer O, Giladi N, Elstein D, Abrahamov A, Turezkite T, Aghai E, Reches A, Bembi B, Zimran A. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM. 1996; 89: 691-694
4. Tayebi N, Reissner KJ, Lau EK, Stubblefield BK, Klineburgess AC, Martin BM, Sidransky E. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease. Pediatr Res. 1998; 43: 571-578
5. Goker-Alpan O, Schiffmann R, Park JK, Stubblefield BK, Tayebi N, Sidransky E. Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3. J Pediatr. 2003; 143: 273-276
6. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003; 24: 197-211
7. Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 2010; 120: 1-12
8. Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009; 361: 1651-1661
9. Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK, Morrison A, Lwin A, Colegial C, Allman JM, Schiffmann R. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab. 2004; 82: 192-207
10. Pchelina SN, Nuzhnyi EP, Emelyanov AK, Boukina TM, Usenko TS, Nikolaev MA, Salogub GN, Yakimovskii AF, Zakharova EY. Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases. Neurosci Lett. 2014; 583: 188-193
11. Gegg ME, Burke D, Heales SJ, Cooper JM, Hardy J, Wood NW, Schapira AH. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol. 2012; 72: 455-463
12. Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet. 2004; 41: 937-940
13. Kovacs GG. Invited review: Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015; 41: 3-23
14. Burrow TA, Sun Y, Prada CE, Bailey L, Zhang W, Brewer A, Wu SW, Setchell KD, Witte D, Cohen MB, Grabowski GA. CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings. Mol Genet Metab. 2015; 114: 233-241
15. Sarnat HB, Flores-Sarnat L. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma. Brain Dev. 2015; 37: 553-562
16. Kovacs GG, Breydo L, Green R, Kis V, Puska G, Lorincz P, Perju-Dumbrava L, Giera R, Pirker W, Lutz M, Lachmann I, Budka H, Uversky VN, Molnár K, László L. Intracellular processing of diseaseassociated α-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis. 2014; 69: 76-92
17. Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, Leisser I, Verchère J, Baron T, Alafuzoff I, Budka H, Perret-Liaudet A, Lachmann I. An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathol. 2012; 124: 37-50
18. Kuusisto E, Kauppinen T, Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol. 2008; 34: 169-180
19. Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell. 2011; 146: 37-52
20. Petersen K, Olesen OF, Mikkelsen JD. Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex. Neuroscience. 1999; 91: 651-659
21. Schulz-Schaeffer WJ. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol. 2010; 120: 131-143
22. Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M. Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport. Ann Neurol. 2012; 72: 517-524
23. Ginns EI, Mak SK, Ko N, Karlgren J, Akbarian S, Chou VP, Guo Y, Lim A, Samuelsson S, LaMarca ML, Vazquez-DeRose J, Manning-Bog AB. Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction. Mol Genet Metab. 2014; 111: 152-162
24. Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Martí MJ, Hernández I, Valldeoriola F, Reñé R, Ribalta T. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014; 29: 1010-1018
25. Cullen V, Sardi SP, Ng J, Xu YH, Sun Y, Tomlinson JJ, Kolodziej P, Kahn I, Saftig P, Woulfe J, Rochet JC, Glicksman MA, Cheng SH, Grabowski GA, Shihabuddin LS, Schlossmacher MG. Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing. Ann Neurol. 2011; 69: 940-953
26. Siebert M, Sidransky E, Westbroek W. Glucocerebrosidase is shaking up the synucleinopathies. Brain. 2014; 137: 1304-1322
27. Várkonyi J, Rosenbaum H, Baumann N, MacKenzie JJ, Simon Z, Aharon-Peretz J, Walker JM, Tayebi N, Sidransky E. Gaucher disease associated with parkinsonism: four further case reports. Am J Med Genet A. 2003; 116A: 348-351
28. Tayebi N, Callahan M, Madike V, Stubblefield BK, Orvisky E, Krasnewich D, Fillano JJ, Sidransky E. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab. 2001; 73: 313-321
29. Itokawa K, Tamura N, Kawai N, Shimazu K, Ishii K. Parkinsonism in type I Gaucher's disease. Intern Med. 2006; 45: 1165-1167
30. Biegstraaten M, van Schaik IN, Aerts JM, Hollak CE. 'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature. J Inherit Metab Dis. 2008; 31: 337-349
31. Myerowitz R, Mizukami H, Richardson KL, Finn LS, Tifft CJ, Proia RL. Global gene expression in a type 2 Gaucher disease brain. Mol Genet Metab. 2004; 83: 288-296
32. Hamlat A, Saikali S, Lakehal M, Pommereuil M, Morandi X. Cauda equina syndrome due to an intra-dural sacral cyst in type-1 Gaucher disease. Eur Spine J. 2004; 13: 249-252
33. Spitz M, Rozenberg R, Silveira PA, Barbosa ER. Parkinsonism in type 1 Gaucher's disease. J Neurol Neurosurg Psychiatry. 2006; 77: 709-710
34. Alonso-Canovas A, Katschnig P, Tucci A, Carecchio M, Wood NW, Edwards M, Martínez Castrillo JC, Burke D, Heales S, Bhatia KP. Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: case report and literature review. Mov Disord. 2010; 25: 1506-1509
35. Kraoua I, Stirnemann J, Ribeiro MJ, Rouaud T, Verin M, Annic A, Rose C, Defebvre L, Réménieras L, Schüpbach M, Belmatoug N, Vidailhet M, Sedel F. Parkinsonism in Gaucher's disease type 1: ten new cases and a review of the literature. Mov Disord. 2009; 24: 1524-1530